共 97 条
- [1] Alvar J(2012)Leishmaniasis worldwide and global estimates of its incidence PLoS One 7 e35671-40
- [2] Velez ID(2018)Leishmaniasis in humans: drug or vaccine therapy? Drug Des Devel Ther 12 25-521
- [3] Bern C(2017)Drug resistance and treatment failure in leishmaniasis: a 21st- challenge PLoS Negl Trop Dis 11 e0006052-1231
- [4] Ghorbani M(2019)Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy Front Immunol 10 670-630
- [5] Farhoudi R(2021)Anti-interleukin-10 unleashes transcriptional response to leishmanial antigens in visceral leishmaniasis patients J Infect Dis 223 517-456
- [6] Ponte-Sucre A(2000)IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis Cytokine 12 1228-184
- [7] Gamarro F(2007)T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis Mem Inst Oswaldo Cruz 102 625-993
- [8] Dayakar A(1994)Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection J Exp Med 179 447-799
- [9] Chandrasekaran S(2016)Regulation of immunity during visceral Leishmania infection Parasit Vectors 9 118-80
- [10] Kuchipudi SV(2013)Mechanisms of immune evasion in leishmaniasis Adv Appl Microbiol 82 155-395